title: Cochrane Corner: is there a benefit of using intracoronary vasodilators in ST segment elevation myocardial infarction?
authors.forename: Pascal
authors.initials: P
authors.lastname: Meier
authors.forename: Adam
authors.initials: A
authors.lastname: Timmis
authors.forename: Juan-Pablo
authors.initials: JP
authors.lastname: Casas
authors.forename: Catherine
authors.initials: C
authors.lastname: Otto
mesh_terms: D003326:Coronary Circulation / Q000187:drug effects*; D019317:Evidence-Based Medicine; D006801:Humans; D008833:Microcirculation / Q000187:drug effects*; D009203:Myocardial Infarction / Q000503:physiopathology / Q000628:therapy*; D054318:No-Reflow Phenomenon / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects; D012196:Review Literature as Topic; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014665:Vasodilator Agents
keywords: EBM; INTERVENTIONAL CARDIOLOGY